Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans Assay-Reference-Cited by-同舟云学术

Identification of Antifungal Compounds Active against Candida albicans Using an Improved High-Throughput Caenorhabditis elegans Assay

Published:2009-09-14 Issue:9 Volume:4 Page:e7025
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Okoli Ikechukwu,Coleman Jeffrey J.,Tempakakis Emmanouil,An W. Frank,Holson Edward,Wagner Florence,Conery Annie L.,Larkins-Ford Jonah,Wu Gang,Stern Andy,Ausubel Frederick M.,Mylonakis Eleftherios

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. The worm has turned - microbial virulence modeled in Caenorhabditis elegans.;CD Sifri;Trends Microbiol,2005

2. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi.;E Mylonakis;PLoS Pathog,2007

3. Nosocomial bloodstream infections in United States hospitals: a three year analysis.;MB Edmond;Clin Infect Dis,1999

4. Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals.;E Mylonakis;Mol Microbiol,2004

5. Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach.;RJ Tang;Infect Immun,2005

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vertebrate and invertebrate animal infection models of Candida auris pathogenicity;Current Opinion in Microbiology;2024-08

2. Evaluation of the in vitro and in vivo antimicrobial activity of alkaloids prepared from Chelidonium majus L. using MRSA- infected C. elegans as a model host;Fitoterapia;2024-06

3. Alternative Non-Mammalian Animal and Cellular Methods for the Study of Host–Fungal Interactions;Journal of Fungi;2023-09-19

4. Concentration of Total Alkaloids from Celandine <i>Chelidonium Majus L.</i> And its Mechanism of Antibacterial Activity;2023

5. Novel avenues for identification of new antifungal drugs and current challenges;Expert Opinion on Drug Discovery;2022-07-21